Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a Section 232 investigation Read more
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment Read more
Revamping multi-tier distribution: Ensuring consistent availability for India’s pharma growth Read more
Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation Read more
